Nanogen, Inc., global developer of molecular diagnostic test kits, announced remarkable revenue and cost figures for the third quarter of 2008. Not only did revenues increase by a whopping 64% to $13.8 million compared to the same quarter in 2007, the company also managed to slash sales costs by 31%.

During the Jefferies 2nd Annual Healthcare Conference in New York, David S. Barlow, the chairman and CEO of Molecular Insight Pharmaceuticals, Inc. (MIPI) presented on the fast growing field of molecular medicine.